Profil
Jörgen Persson worked as the Chief Executive Officer at Dunross & Co. AB from 2010 to 2013 and also worked at Cellectricon AB as a Director.
Ehemalige bekannte Positionen von Jörgen Persson
| Unternehmen | Position | Ende |
|---|---|---|
Dunross & Co. AB
 Dunross & Co. AB Investment ManagersFinance Dunross & Co. AB (D&C) is a private placement firm located in Gothenburg, Sweden. D&C was established in 1989 as an independent firm owned and managed by their CEO and founder, Sven Norfeldt. | Vorstandsvorsitzender | 01.08.2013 |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Dunross & Co. AB
Dunross & Co. AB Investment ManagersFinance Dunross & Co. AB (D&C) is a private placement firm located in Gothenburg, Sweden. D&C was established in 1989 as an independent firm owned and managed by their CEO and founder, Sven Norfeldt. | Finance |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
